It is well known that age-related clonal hematopoiesis is associated with increase in the risk of hematologic cancer and the majority of the variants occurred in three genes: DNMT3A, TET2, and ASXL1 [47–49]. This evidence concerns the gene ASXL1 and hematopoietic and lymphoid cell neoplasm.